Non-invasive glucose monitoring device could measure your glucose without hurt your finger. Non-invasive glucose monitoring device refers to the measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from the disease) without drawing blood, puncturing the skin, or causing pain or trauma.In this report, we study both disposable sensors and durable systems.
The global Non-Invasive Glucose Monitoring market is projected to grow from US$ 5290.7 million in 2023 to US$ 6428.6 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.3% during the forecast period.
Market is really concentrated. Abbott and DexCom accounted for 54.33% and 47.03% market share in 2019.
Report Includes:
This report presents an overview of global market for Non-Invasive Glucose Monitoring, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Non-Invasive Glucose Monitoring, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Non-Invasive Glucose Monitoring, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Non-Invasive Glucose Monitoring sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Non-Invasive Glucose Monitoring market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Non-Invasive Glucose Monitoring sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Medtronic, Roche, Bayer AG, B. Braun, Nipro Diagnostics, Life Scan Inc.(J&J), Arkray Devices and Nova Biomedical, etc.
By Company
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
Sinocare
Hybio Pharmaceutical
Lepu Medical
Yuyue Medical
Segment by Type
Wearable Blood Glucose Monitoring Systems
Table Top Blood Glucose Monitoring Systems
Segment by Application
Hospitals
Clinics
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Non-Invasive Glucose Monitoring in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Non-Invasive Glucose Monitoring manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Invasive Glucose Monitoring sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Non-Invasive Glucose Monitoring Product Introduction
1.2 Market by Type
1.2.1 Global Non-Invasive Glucose Monitoring Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Wearable Blood Glucose Monitoring Systems
1.2.3 Table Top Blood Glucose Monitoring Systems
1.3 Market by Application
1.3.1 Global Non-Invasive Glucose Monitoring Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Non-Invasive Glucose Monitoring Sales Estimates and Forecasts 2018-2029
2.2 Global Non-Invasive Glucose Monitoring Revenue by Region
2.2.1 Global Non-Invasive Glucose Monitoring Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Non-Invasive Glucose Monitoring Revenue by Region (2018-2023)
2.2.3 Global Non-Invasive Glucose Monitoring Revenue by Region (2024-2029)
2.2.4 Global Non-Invasive Glucose Monitoring Revenue Market Share by Region (2018-2029)
2.3 Global Non-Invasive Glucose Monitoring Sales Estimates and Forecasts 2018-2029
2.4 Global Non-Invasive Glucose Monitoring Sales by Region
2.4.1 Global Non-Invasive Glucose Monitoring Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Non-Invasive Glucose Monitoring Sales by Region (2018-2023)
2.4.3 Global Non-Invasive Glucose Monitoring Sales by Region (2024-2029)
2.4.4 Global Non-Invasive Glucose Monitoring Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Non-Invasive Glucose Monitoring Sales by Manufacturers
3.1.1 Global Non-Invasive Glucose Monitoring Sales by Manufacturers (2018-2023)
3.1.2 Global Non-Invasive Glucose Monitoring Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-Invasive Glucose Monitoring in 2022
3.2 Global Non-Invasive Glucose Monitoring Revenue by Manufacturers
3.2.1 Global Non-Invasive Glucose Monitoring Revenue by Manufacturers (2018-2023)
3.2.2 Global Non-Invasive Glucose Monitoring Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Non-Invasive Glucose Monitoring Revenue in 2022
3.3 Global Key Players of Non-Invasive Glucose Monitoring, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Non-Invasive Glucose Monitoring Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Non-Invasive Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Non-Invasive Glucose Monitoring, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Non-Invasive Glucose Monitoring, Product Offered and Application
3.8 Global Key Manufacturers of Non-Invasive Glucose Monitoring, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-Invasive Glucose Monitoring Sales by Type
4.1.1 Global Non-Invasive Glucose Monitoring Historical Sales by Type (2018-2023)
4.1.2 Global Non-Invasive Glucose Monitoring Forecasted Sales by Type (2024-2029)
4.1.3 Global Non-Invasive Glucose Monitoring Sales Market Share by Type (2018-2029)
4.2 Global Non-Invasive Glucose Monitoring Revenue by Type
4.2.1 Global Non-Invasive Glucose Monitoring Historical Revenue by Type (2018-2023)
4.2.2 Global Non-Invasive Glucose Monitoring Forecasted Revenue by Type (2024-2029)
4.2.3 Global Non-Invasive Glucose Monitoring Revenue Market Share by Type (2018-2029)
4.3 Global Non-Invasive Glucose Monitoring Price by Type
4.3.1 Global Non-Invasive Glucose Monitoring Price by Type (2018-2023)
4.3.2 Global Non-Invasive Glucose Monitoring Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Non-Invasive Glucose Monitoring Sales by Application
5.1.1 Global Non-Invasive Glucose Monitoring Historical Sales by Application (2018-2023)
5.1.2 Global Non-Invasive Glucose Monitoring Forecasted Sales by Application (2024-2029)
5.1.3 Global Non-Invasive Glucose Monitoring Sales Market Share by Application (2018-2029)
5.2 Global Non-Invasive Glucose Monitoring Revenue by Application
5.2.1 Global Non-Invasive Glucose Monitoring Historical Revenue by Application (2018-2023)
5.2.2 Global Non-Invasive Glucose Monitoring Forecasted Revenue by Application (2024-2029)
5.2.3 Global Non-Invasive Glucose Monitoring Revenue Market Share by Application (2018-2029)
5.3 Global Non-Invasive Glucose Monitoring Price by Application
5.3.1 Global Non-Invasive Glucose Monitoring Price by Application (2018-2023)
5.3.2 Global Non-Invasive Glucose Monitoring Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Non-Invasive Glucose Monitoring Market Size by Type
6.1.1 US & Canada Non-Invasive Glucose Monitoring Sales by Type (2018-2029)
6.1.2 US & Canada Non-Invasive Glucose Monitoring Revenue by Type (2018-2029)
6.2 US & Canada Non-Invasive Glucose Monitoring Market Size by Application
6.2.1 US & Canada Non-Invasive Glucose Monitoring Sales by Application (2018-2029)
6.2.2 US & Canada Non-Invasive Glucose Monitoring Revenue by Application (2018-2029)
6.3 US & Canada Non-Invasive Glucose Monitoring Market Size by Country
6.3.1 US & Canada Non-Invasive Glucose Monitoring Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Non-Invasive Glucose Monitoring Sales by Country (2018-2029)
6.3.3 US & Canada Non-Invasive Glucose Monitoring Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Non-Invasive Glucose Monitoring Market Size by Type
7.1.1 Europe Non-Invasive Glucose Monitoring Sales by Type (2018-2029)
7.1.2 Europe Non-Invasive Glucose Monitoring Revenue by Type (2018-2029)
7.2 Europe Non-Invasive Glucose Monitoring Market Size by Application
7.2.1 Europe Non-Invasive Glucose Monitoring Sales by Application (2018-2029)
7.2.2 Europe Non-Invasive Glucose Monitoring Revenue by Application (2018-2029)
7.3 Europe Non-Invasive Glucose Monitoring Market Size by Country
7.3.1 Europe Non-Invasive Glucose Monitoring Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Non-Invasive Glucose Monitoring Sales by Country (2018-2029)
7.3.3 Europe Non-Invasive Glucose Monitoring Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Non-Invasive Glucose Monitoring Market Size
8.1.1 China Non-Invasive Glucose Monitoring Sales (2018-2029)
8.1.2 China Non-Invasive Glucose Monitoring Revenue (2018-2029)
8.2 China Non-Invasive Glucose Monitoring Market Size by Application
8.2.1 China Non-Invasive Glucose Monitoring Sales by Application (2018-2029)
8.2.2 China Non-Invasive Glucose Monitoring Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Non-Invasive Glucose Monitoring Market Size by Type
9.1.1 Asia Non-Invasive Glucose Monitoring Sales by Type (2018-2029)
9.1.2 Asia Non-Invasive Glucose Monitoring Revenue by Type (2018-2029)
9.2 Asia Non-Invasive Glucose Monitoring Market Size by Application
9.2.1 Asia Non-Invasive Glucose Monitoring Sales by Application (2018-2029)
9.2.2 Asia Non-Invasive Glucose Monitoring Revenue by Application (2018-2029)
9.3 Asia Non-Invasive Glucose Monitoring Sales by Region
9.3.1 Asia Non-Invasive Glucose Monitoring Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Non-Invasive Glucose Monitoring Revenue by Region (2018-2029)
9.3.3 Asia Non-Invasive Glucose Monitoring Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Non-Invasive Glucose Monitoring Market Size by Type
10.1.1 Middle East, Africa and Latin America Non-Invasive Glucose Monitoring Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Non-Invasive Glucose Monitoring Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Non-Invasive Glucose Monitoring Market Size by Application
10.2.1 Middle East, Africa and Latin America Non-Invasive Glucose Monitoring Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Non-Invasive Glucose Monitoring Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Non-Invasive Glucose Monitoring Sales by Country
10.3.1 Middle East, Africa and Latin America Non-Invasive Glucose Monitoring Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Non-Invasive Glucose Monitoring Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Non-Invasive Glucose Monitoring Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Overview
11.1.3 Abbott Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Abbott Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Medtronic
11.2.1 Medtronic Company Information
11.2.2 Medtronic Overview
11.2.3 Medtronic Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Medtronic Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Medtronic Recent Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Overview
11.3.3 Roche Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Roche Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
11.4 Bayer AG
11.4.1 Bayer AG Company Information
11.4.2 Bayer AG Overview
11.4.3 Bayer AG Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Bayer AG Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bayer AG Recent Developments
11.5 B. Braun
11.5.1 B. Braun Company Information
11.5.2 B. Braun Overview
11.5.3 B. Braun Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 B. Braun Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 B. Braun Recent Developments
11.6 Nipro Diagnostics
11.6.1 Nipro Diagnostics Company Information
11.6.2 Nipro Diagnostics Overview
11.6.3 Nipro Diagnostics Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Nipro Diagnostics Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Nipro Diagnostics Recent Developments
11.7 Life Scan Inc.(J&J)
11.7.1 Life Scan Inc.(J&J) Company Information
11.7.2 Life Scan Inc.(J&J) Overview
11.7.3 Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Life Scan Inc.(J&J) Recent Developments
11.8 Arkray Devices
11.8.1 Arkray Devices Company Information
11.8.2 Arkray Devices Overview
11.8.3 Arkray Devices Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Arkray Devices Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Arkray Devices Recent Developments
11.9 Nova Biomedical
11.9.1 Nova Biomedical Company Information
11.9.2 Nova Biomedical Overview
11.9.3 Nova Biomedical Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Nova Biomedical Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Nova Biomedical Recent Developments
11.10 Bionime Corporation
11.10.1 Bionime Corporation Company Information
11.10.2 Bionime Corporation Overview
11.10.3 Bionime Corporation Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Bionime Corporation Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bionime Corporation Recent Developments
11.11 Sinocare
11.11.1 Sinocare Company Information
11.11.2 Sinocare Overview
11.11.3 Sinocare Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Sinocare Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sinocare Recent Developments
11.12 Hybio Pharmaceutical
11.12.1 Hybio Pharmaceutical Company Information
11.12.2 Hybio Pharmaceutical Overview
11.12.3 Hybio Pharmaceutical Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Hybio Pharmaceutical Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Hybio Pharmaceutical Recent Developments
11.13 Lepu Medical
11.13.1 Lepu Medical Company Information
11.13.2 Lepu Medical Overview
11.13.3 Lepu Medical Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Lepu Medical Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Lepu Medical Recent Developments
11.14 Yuyue Medical
11.14.1 Yuyue Medical Company Information
11.14.2 Yuyue Medical Overview
11.14.3 Yuyue Medical Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Yuyue Medical Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Yuyue Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-Invasive Glucose Monitoring Industry Chain Analysis
12.2 Non-Invasive Glucose Monitoring Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-Invasive Glucose Monitoring Production Mode & Process
12.4 Non-Invasive Glucose Monitoring Sales and Marketing
12.4.1 Non-Invasive Glucose Monitoring Sales Channels
12.4.2 Non-Invasive Glucose Monitoring Distributors
12.5 Non-Invasive Glucose Monitoring Customers
13 Market Dynamics
13.1 Non-Invasive Glucose Monitoring Industry Trends
13.2 Non-Invasive Glucose Monitoring Market Drivers
13.3 Non-Invasive Glucose Monitoring Market Challenges
13.4 Non-Invasive Glucose Monitoring Market Restraints
14 Key Findings in The Global Non-Invasive Glucose Monitoring Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
Sinocare
Hybio Pharmaceutical
Lepu Medical
Yuyue Medical
听
听
*If Applicable.
